Cardiff Oncology, Inc. · NASDAQ:CRDF
The Vanguard Group reported a 5.60% stake in Cardiff Oncology, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.60% stake in Cardiff Oncology, Inc., 3,728,334 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 3,728,334
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.60% | 3,728,334 |
Source
Related
- Cardiff Oncology, Inc.
- The Vanguard Group
- Cardiff Oncology, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Pace Gary W · Jul 16, 2026
- Form 4 · Mohindru Mani · Jul 16, 2026
- Form 4 · Mohindru Mani · Jun 22, 2026
- Form 4 · Pace Gary W · Jun 22, 2026